Loading...

PE/Cyanine7 anti-mouse/human CD11b Antibody

Pricing & Availability
Clone
M1/70 (See other available formats)
Regulatory Status
RUO
Other Names
αM integrin, Mac-1, Mo1, CR3, Ly-40, C3biR, ITGAM
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
M1slash70_PECy7_042706
C57BL/6 mouse bone marrow cells were stained with CD11b (clone M1/70) PE/Cyanine7 (filled histogram) or rat IgG2b, κ PE/Cyanine7 isotype control (open histogram) (gated on total cells).
  • M1slash70_PECy7_042706
    C57BL/6 mouse bone marrow cells were stained with CD11b (clone M1/70) PE/Cyanine7 (filled histogram) or rat IgG2b, κ PE/Cyanine7 isotype control (open histogram) (gated on total cells).
Compare all formats See PE/Cyanine7 spectral data
Cat # Size Price Quantity Check Availability Save
101215 25 µg 70€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
101216 100 µg 169€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11b is a 170 kD glycoprotein also known as αM integrin, Mac-1 α subunit, Mol, CR3, and Ly-40. CD11b is a member of the integrin family, primarily expressed on granulocytes, monocytes/macrophages, dendritic cells, NK cells, and subsets of T and B cells. CD11b non-covalently associates with CD18 (β2 integrin) to form Mac-1. Mac-1 plays an important role in cell-cell interaction by binding its ligands ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, and fibrinogen.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse, Human, Cynomolgus, Rhesus
Reported Reactivity
Chimpanzee, Baboon, Rabbit
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
C57BL/10 splenocytes
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE/Cyanine7 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Clone M1/70 has been verified for immunocytochemistry (ICC) and frozen immunohistochemistry (IHC-F).

Additional reported applications (for relevant formats of this clone) include: immunoprecipitation1,4, in vitro blocking3,9,12, depletion2,8, immunofluorescence microscopy6,7,10, immunohistochemistry of acetone-fixed frozen sections5,11-13, and spatial biology (IBEX)35,36. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) (Cat. No. 101248).

Application References

(PubMed link indicates BioLegend citation)
  1. Springer T, et al. 1978. Eur. J. Immunol. 8:539. (IP)
  2. Ault K and Springer T. 1981. J. Immunol. 126:359. (Deplete)
  3. Springer TA, et al. 1982. Immunol. Rev. 68:171. (Block)
  4. Ho MK and Springer TA. 1983. J. Biol. Chem. 258:2766. (IP)
  5. Flotte TJ, et al. 1983. Am. J. Pathol. 111:112. (IHC)
  6. Noel GJ, et al. 1990. J. Clin. Invest. 85:208. (IF)
  7. Allen LA and Aderem A. 1996. J. Exp. Med. 184:627 (IF)
  8. D'Amico A and Wu L. 2003. J. Exp. Med. 198:293. (Deplete)
  9. Brickson SJ, et al. 2003. Appl Physiol. 95:969. (Block)
  10. Clatworthy MR and Smith KG. 2004. J. Exp. Med. 199:717. (IF)
  11. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  12. Zhang Y, et al. 2002. J. Immunol. 168:3088. (IHC)
  13. Iwasaki A and Kelsall BL. 2001. J. Immunol. 166:4884 (IHC, FC)
  14. Tailleux L. 2003. J. Exp. Med. 197:121. (Block, FC)
  15. Olver S, et al. 2006. Cancer Research 66:571. (FC)
  16. Tan SL, et al. 2006. J. Immunol. 176:2872. (FC) PubMed
  17. Ponomarev ED, et al. 2006. J. Immunol. 176:1402. (FC)
  18. Dzhagalov I, et al. 2007. Blood 109:1620. (FC)
  19. Fazilleau N, et al. 2007. Nature Immunol. 8:753.
  20. Rasmussen JW, et al. 2006. Infect. Immun.74:6590. PubMed
  21. Napimoga MH, et al. 2008. J. Immunol. 180:609. PubMed
  22. Elqaraz-Carmon V, et al. 2008. J. Lipid. Res. 49:1894. PubMed
  23. Kim DD, et al. 2008. Blood 112:1109. PubMed
  24. Guo Y, et al. 2008. Blood 112:480. PubMed
  25. Norian LA, et al. 2009. Cancer Res. 69:3086. (FC) PubMed
  26. Baumgartner CK, et al. 2010. J. Immunol. 184:573. PubMed
  27. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  28. Whiteland J, et al. 1995. J. Histochem. Cytochem. 43:313. (IHC)
  29. Weber GF, et al. 2014. J Exp Med. 211:1243. PubMed
  30. Ashok A, et al. 2015. Toxicol Sci. 143:64. PubMed
  31. Price PJ, et al. 2015. J Immunol. 194:1164. PubMed
  32. Doni A, et al. 2015. J Exp Med. 212:905. PubMed
  33. Ferreira R, et al. 2016. J Infect Dis. 213: 669 - 673. PubMed
  34. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
  35. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  36. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Wang L, et al. 2021. J Nanobiotechnology. 19:56. PubMed
  2. Kuo PC, et al. 2021. Brain Commun. 3:fcab187. PubMed
  3. Rosina M, et al. 2022. Cell Metab. 34:533. PubMed
  4. Cheresh P, et al. 2021. Int J Mol Sci. 22:. PubMed
  5. Deng R, et al. 2022. Adv Sci (Weinh). 9:e2103343. PubMed
  6. Odom CV, et al. 2021. J Immunol. 207:1891. PubMed
  7. Denny L, et al. 2021. Clin Transl Immunology. 10:e1234. PubMed
  8. Janbandhu V, et al. 2022. Cell Stem Cell. 29:281. PubMed
  9. Cohen K, et al. 2021. Cell Rep. 37:110026. PubMed
  10. Aimaitijiang A, et al. 2022. Genes Cells. 27:25. PubMed
  11. Schnell A, et al. 2021. Cell. 184:6281. PubMed
  12. Zhou Y, et al. 2022. Br J Pharmacol. 179:1978. PubMed
  13. Hiyoshi H, et al. 2022. Cell Host Microbe. 30:163. PubMed
  14. Wang B, et al. 2022. EMBO J. 41:e108946. PubMed
  15. Wang S, et al. 2022. Sci Adv. 8:eabn3883. PubMed
  16. Du Y, et al. 2022. J Exp Med. 219: . PubMed
  17. Pannunzio B, et al. 2022. Cells. 11: . PubMed
  18. Marié IJ, et al. 2022. Bio Protoc. 12:e4438. PubMed
  19. Hong Y, et al. 2022. J Leukoc Biol. 112:425. PubMed
  20. Que W, et al. 2022. Sci Adv. 8:eabo4413. PubMed
  21. Liu Z, et al. 2022. Cancer Commun (Lond). 42:971. PubMed
  22. Zhang X, et al. 2022. EBioMedicine. 84:104275. PubMed
  23. Hindy G, et al. 2022. J Clin Invest. 132: . PubMed
  24. Lu Z, et al. 2022. Cell Rep. 41:111482. PubMed
  25. Mansouri S, et al. 2022. J Immunol. 209:2114. PubMed
  26. Yoo HJ, et al. 2022. Cell Rep. 41:111598. PubMed
  27. Papaxenopoulou LA, et al. 2022. iScience. 25:105522. PubMed
  28. Zhang Y, et al. 2022. Front Oncol. 12:1042250. PubMed
  29. He Y, et al. 2022. Front Immunol. 13:986202. PubMed
  30. Lee DE, et al. 2022. Nat Commun. 13:7613. PubMed
  31. Kraemer AN, et al. 2022. Front Immunol. 13:933191. PubMed
  32. Choi H, et al. 2023. J Nanobiotechnology. 21:5. PubMed
  33. Wang D, et al. 2023. J Exp Clin Cancer Res. 42:26. PubMed
  34. Leinenga G, et al. 2023. Bioeng Transl Med. 8:e10329. PubMed
  35. Wang R, et al. 2023. iScience. 26:105954. PubMed
  36. Slusarczyk P, et al. 2023. Elife. 12: . PubMed
  37. Ernst MPT, et al. 2023. Hemasphere. 7:e824. PubMed
  38. Drijvers JM, et al. 2021. Cancer Immunol Res. 9:184. PubMed
  39. Yeh CH, et al. 2022. Immunity. 55:272. PubMed
  40. Parsons M, et al. 2014. J Immunol. 192:1361. PubMed
  41. Tebartz C, et al. 2015. J Immunol. 194:1100. PubMed
  42. Quispe Calla N, et al. 2016. Sci Rep. 6:37723. PubMed
  43. D'Alessandro G, et al. 2020. Eur J Immunol. 50:705. PubMed
  44. DeSouza-Vieira T, et al. 2020. Cell Rep. 33:108317. PubMed
  45. Gogoi H, et al. 2020. Front Immunol. 1.620833333. PubMed
  46. Liu K, et al. 2021. Cell Metabolism. 33(3):666-675.e4. PubMed
  47. Hatzi K, et al. 2019. Nat Immunol. 20:86. PubMed
  48. Tran NT, et al. 2019. Cell Rep. 28:3510. PubMed
  49. Lin C et al. 2019. Immunity. 50(1):137-151 . PubMed
  50. Okunuki Y, et al. 2018. Proc Natl Acad Sci U S A. 115:E6264. PubMed
  51. Yu X, et al. 2020. Nat Commun. 11:1110. PubMed
  52. Sheng YH, et al. 2022. Cell Mol Gastroenterol Hepatol. 14:789. PubMed
  53. Banerjee K, et al. 2023. Eur J Immunol. 53:e2250161. PubMed
  54. Mela V, et al. 2023. Mol Neurobiol. 60:3044. PubMed
  55. Schönberger K, et al. 2023. Anal Chem. 95:4325. PubMed
  56. Li L, et al. 2023. iScience. 26:106095. PubMed
  57. Tang C, et al. 2023. Nat Commun. 14:1493. PubMed
  58. Gupta T, et al. 2023. Front Immunol. 14:1044703. PubMed
  59. MacPherson KP, et al. 2023. Front Cell Neurosci. 17:895017. PubMed
  60. Martins Nascentes Melo L, et al. 2023. J Immunother Cancer. 11:. PubMed
  61. Pastrez PRA, et al. 2023. Cancers (Basel). 15:. PubMed
  62. Yao H, et al. 2023. Front Immunol. 14:1147674. PubMed
  63. Hernandez VG, et al. 2023. Glia. 71:1960. PubMed
  64. Kim BH, et al. 2023. Sci Rep. 13:6577. PubMed
  65. Lu Y, et al. 2023. J Transl Med. 21:339. PubMed
  66. Bobadilla Muñoz M, et al. 2023. Front Cell Dev Biol. 11:1128534. PubMed
  67. Doloff JC, et al. 2023. Sci Adv. 9:eade9488. PubMed
  68. Ye S, et al. 2023. Front Oncol. 13:1202750. PubMed
  69. Kitagawa S, et al. 2022. NPJ Vaccines. 7:115. PubMed
  70. Rodrigues M, et al. 2022. Biochem J. 479:1891. PubMed
  71. Jung MY, et al. 2022. Neurooncol Adv. 4:vdac017. PubMed
  72. Schönberger K, et al. 2022. Cell Stem Cell. 29:131. PubMed
  73. Di Martile M, et al. 2020. J Immunother Cancer. 8:. PubMed
  74. Sharma GP, et al. 2021. PLoS One. 16:e0259042. PubMed
  75. Li Z, et al. 2021. Immunology. 163:105. PubMed
  76. Correa S, et al. 2020. ACS Nano. 14:2224. PubMed
  77. Kim JS, et al. 2020. Immunity. 54(1):176-190.e7. PubMed
  78. Gazit R, et al. 2014. J Exp Med. 211:1315. PubMed
  79. Giorgetti E, et al. 2020. Cell Reports. 29(6):1539-1554.e7.. PubMed
  80. Thelin MA, et al. 2017. Diabetes. 66:2220. PubMed
  81. Zhang LJ, et al. 2019. Immunity. 50:121. PubMed
  82. Abels ER et al. 2019. Cell Rep. 28(12):3105-3119 . PubMed
  83. Frisbee AL, et al. 2019. Nat Commun. 10:2712. PubMed
  84. Groza D, et al. 2018. Oncoimmunology. 7:e1424676. PubMed
  85. Alissafi T, et al. 2018. J Clin Invest. 128:3840. PubMed
  86. Iwamoto H et al. 2018. Cell metabolism. 28(1):104-117 . PubMed
  87. McGill BE et al. 2018. The Journal of Neuroscience. 38(1):200-219 . PubMed
  88. Wei H, et al. 2021. Malar J. 20:89. PubMed
  89. Van Den Eeckhout B, et al. 2020. NPJ Vaccines. 5:64. PubMed
  90. Hickey A, et al. 2021. Front Microbiol. 12:653587. PubMed
  91. Morgan PK, et al. 2021. J Biol Chem. 297:101341. PubMed
  92. Yang C, et al. 2021. J Immunother Cancer. 9:. PubMed
  93. Piepke M, et al. 2021. J Neuroinflammation. 18:265. PubMed
  94. Jiang W, et al. 2021. Oncol Lett. 22:625. PubMed
  95. Chen T, et al. 2021. JCI Insight. 6:. PubMed
  96. Radovanovic I, et al. 2014. J Immunol. 193:1290. PubMed
  97. Zasłona Z, et al. 2014. J Immunol. 193:4245. PubMed
  98. Zheng W, et al. 2021. Wellcome Open Research. 6:52. PubMed
  99. Mogilenko DA, et al. 2020. Immunity. 54(1):99-115.e12. PubMed
  100. Riether C, et al. 2021. Cell Reports. 34(4):108663. PubMed
  101. Yu K, et al. 2021. Cell Reports. 35(12):109273. PubMed
  102. Kurelac I, et al. 2019. Nat Commun. 10:903. PubMed
  103. Kobayashi Y, et al. 2018. PLoS One. 13:e0195008. PubMed
  104. Delás MJ, et al. 2019. Cell Rep. 27:719. PubMed
  105. Yang X, et al. 2020. Blood Sci. 2:89. PubMed
  106. Deslyper G, et al. 2021. Parasitology. 148:539. PubMed
  107. Shen H, et al. 2015. Infect Immun . 83: 2694 - 2704. PubMed
  108. Periasamy S, et al. 2017. Nat Commun. 8:15564. PubMed
  109. Saggu G, et al. 2018. Nat Commun. 9:5058. PubMed
  110. Yuzhu Hou et al. 2018. Immunity. 49(3):490-503 . PubMed
  111. Bowers E, et al. 2018. Nat Med. 24:95. PubMed
  112. Go DM, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:715. PubMed
  113. Park JA, et al. 2021. J Hematol Oncol. 14:142. PubMed
  114. Zong L, et al. 2021. NPJ Aging Mech Dis. 7:25. PubMed
  115. Almutairi F, et al. 2021. Front Immunol. 12:772288. PubMed
  116. Enriquez AB, et al. 2022. iScience. 25:104305. PubMed
  117. Royzman D, et al. 2022. Front Immunol. 13:1012647. PubMed
  118. Martin R, et al. 2014. J Leukoc Biol. 96:151. PubMed
  119. Shemer A, et al. 2020. Immunity. 53(5):1033-1049.e7. PubMed
  120. Yamamoto K, et al. 2021. Cell Reports. 36(8):109576. PubMed
  121. Uroda T, et al. 2020. Nat Protoc. 15:2107. PubMed
  122. Akhmetzyanova ER, et al. 2019. Front Cell Neurosci. 12:507. PubMed
  123. Lubkin A et al. 2019. Cell host & microbe. 25(3):463-470 . PubMed
  124. Gibson EM, et al. 2019. Cell. 176:43:00. PubMed
  125. Juttukonda LJ, et al. 2017. Cell Host Microbe. 22:531. PubMed
  126. LaFleur MW, et al. 2019. Nat Immunol. 20:1335. PubMed
  127. Somerville TD, et al. 2020. eLife. 9:e53381.. PubMed
  128. Xu X, et al. 2021. J Nanobiotechnology. 19:376. PubMed
  129. Walker FC, et al. 2021. PLoS Pathog. 17:e1009402. PubMed
  130. Johansen AZ, et al. 2022. Pharmaceutics. 14:. PubMed
  131. Liu Y, et al. 2022. Nat Commun. 13:2665. PubMed
  132. Beauchamp EM, et al. 2021. Blood Cancer Discov. 6:. PubMed
  133. Dodagatta-Marri E, et al. 2021. Cell Rep. 36:109309. PubMed
  134. Super M, et al. 2021. Nat Biomed Eng. Online ahead of print. PubMed
  135. Kulkarni NN, et al. 2021. J Biol Chem. 297:100828. PubMed
  136. Jia X, et al. 2021. Front Cell Dev Biol. 9:685522. PubMed
  137. Klopfenstein N, et al. 2021. PLoS Pathog. 17:e1009387. PubMed
  138. Ellis G, et al. 2015. EMBO Rep. 16: 1203-1218. PubMed
  139. Vazquez S, et al. 2015. Exp Hematol. 43: 578-585. PubMed
  140. Shade K, et al. 2015. J Exp Med. 212:457. PubMed
  141. Sasaki K, et al. 2019. Nat Commun. 10:3878. PubMed
  142. Angelidis I, et al. 2019. Nat Commun. 10:963. PubMed
  143. Hore ZL, et al. 2021. Wellcome Open Res. 6:68. PubMed
  144. Wang L, et al. 2021. Cancer Immunol Res. 9:348. PubMed
  145. Enriquez AB, et al. 2022. iScience. 25:104305. PubMed
  146. Shin JE, et al. 2021. Heliyon. 7:e08433. PubMed
  147. Koh F, et al. 2015. Proc Natl Acad Sci U S A. 112:1734. PubMed
  148. Kohn M, et al. 2021. Front Immunol. 580594:12. PubMed
  149. Liang Z, et al. 2020. Pain. 161:2089. PubMed
  150. Vasilijevic J, et al. 2017. PLoS Pathog. 13:e1006650. PubMed
  151. Meeks K, et al. 2009. J Immunol. 183:8026. PubMed
  152. Amo-Aparicio J, et al. 2021. Theranostics. 11:9805. PubMed
  153. Mansouri S, et al. 2021. J Immunol. 206:2233. PubMed
  154. Goldman E, et al. 2021. Cells. 10:. PubMed
  155. Dokoshi T, et al. 2021. J Clin Invest. 131:. PubMed
  156. Pan YC, et al. 2021. Mol Ther Oncolytics. 20:175. PubMed
  157. Aegerter H, et al. 2020. Nat Immunol. 0.975694444. PubMed
  158. Zhang S, et al. 2020. Front Immunol. 1.757638889. PubMed
  159. Kirschbaum K, et al. 2016. Proc Natl Acad Sci U S A. 113: 13227 - 13232. PubMed
  160. Varol D et al. 2017. Immunity. 46(6):1030-1044 . PubMed
  161. Snell LM, et al. 2018. Immunity. 49:678. PubMed
  162. Huang YL, et al. 2021. Commun Biol. 4:229. PubMed
  163. Littwitz-Salomon E, et al. 2021. Nat Commun. 12:5376. PubMed
  164. Synn CB, et al. 2022. Clin Transl Immunology. 11:e1364. PubMed
  165. Xie Z, et al. 2020. Light Sci Appl. 0.486805556. PubMed
  166. Gomzikova MO, et al. 2020. Sci Rep. 10:10740. PubMed
  167. He Y, et al. 2021. Cell Metabolism. 33(5):988-1000.e7. PubMed
  168. Okubo K, et al. 2021. Cell Reports. 35(7):109142. PubMed
  169. Gozgit JM, et al. 2021. Cancer Cell. :. PubMed
  170. Kooreman NG et al. 2018. Cell stem cell. 22(4):501-513 . PubMed
  171. Proto JD et al. 2018. Immunity. 49(4):666-677 . PubMed
  172. Secondini C, et al. 2017. Oncoimmunology. 6:e1316437. PubMed
  173. , et al. 2021. Eur J Immunol. 51:2708. PubMed
  174. Uddin MJ, et al. 2022. Mucosal Immunol. 15:165. PubMed
  175. Wang D, et al. 2021. Nat Commun. 12:2674. PubMed
  176. Jia Q, et al. 2021. Theranostics. 4699:11. PubMed
  177. Dobosz E, et al. 2021. Dis Model Mech. :14. PubMed
  178. Mulas F, et al. 2020. Cell Mol Immunol. . PubMed
  179. Zhu H, et al. 2021. Cell Metabolism. :. PubMed
  180. Bambouskova M, et al. 2021. Cell Reports. 34(10):108756. PubMed
  181. Ringel AE, et al. 2020. Cell. 183(7):1848-1866.e26. PubMed
  182. Pérez-Girón J, et al. 2015. J Vis Exp. 100: 52803. PubMed
  183. Suresh MV, et al. 2019. JCI Insight. 4:e133103. PubMed
  184. Patel S, et al. 2019. Viruses. 0.877083333. PubMed
  185. Bradley KC, et al. 2019. Cell Rep. 28:245. PubMed
  186. Kumar MP, et al. 2018. Cell Rep. 25:1458. PubMed
  187. Steuerman Y et al. 2018. Cell systems. 6(6):679-691 . PubMed
  188. Li H, et al. 2020. Nature. 584:274. PubMed
  189. Sibilio A, et al. 2022. iScience. 25:103790. PubMed
  190. Dey S, et al. 2020. J Immunother Cancer. 8:. PubMed
  191. Shen M, et al. 2022. Nat Cancer. 3:60. PubMed
  192. Liu H, et al. 2022. Front Pharmacol. 13:949316. PubMed
  193. Boulay A, et al. 2015. J Neurosci. 35:4427. PubMed
  194. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  195. Lim CX, et al. 2020. Cell Rep. 3793:30. PubMed
  196. Li Z, et al. 2018. Front Immunol. 9:347. PubMed
  197. Marcus A et al. 2018. Immunity. 49(4):754-763 . PubMed
  198. Van Winkle JA et al. 2018. Cell host & microbe. 24(5):665-676 . PubMed
  199. LaFleur MW, et al. 2019. Nat Commun. 10:1668. PubMed
  200. Wilson DH, et al. 2020. Nat Commun. 0.767361111. PubMed
  201. Tran NT, et al. 2020. STAR Protocols. 1(1):100028. PubMed
  202. Endoh M, et al. 2020. Cell Reports. 30(6):1823-1834. PubMed
  203. Monaghan KL, et al. 2020. J Vis Exp. . PubMed
  204. Frenis K, et al. 2021. Basic Res Cardiol. 31:116. PubMed
  205. Crouse B, et al. 2020. NPJ Vaccines. 0.277083333. PubMed
  206. Lee L, et al. 2016. PLoS One. 11:e0167693. PubMed
  207. Arce-Cerezo A, et al. 2015. Sci Rep. 5: 1448. PubMed
  208. Ballet R, et al. 2014. PLoS Pathog. 10:1004550. PubMed
  209. Choi EW, et al. 2020. Sci Rep. 10:12001. PubMed
  210. Denny JE, et al. 2019. Sci Rep. 2.786111111. PubMed
  211. Liu C et al. 2019. Immunity. 51(2):381-397 . PubMed
  212. Simula L et al. 2018. Cell reports. 25(11):3059-3073 . PubMed
  213. Gao C, et al. 2017. Mol Neurobiol.. 10.1007/s12035-016-0318-0. PubMed
  214. Khare P, et al. 2017. J Autoimmun. 10.1016/j.jaut.2017.09.002. PubMed
  215. Wuggenig P, et al. 2020. Commun Biol. 3:130. PubMed
  216. Merrell AJ, et al. 2021. Hepatology. 74:444. PubMed
  217. Chen C, et al. 2021. J Virol. 95:e0082921. PubMed
  218. Yu W, et al. 2022. Nat Commun. 13:3544. PubMed
  219. Scholz F, et al. 2015. J Immunol. 195: 2335-2342. PubMed
  220. Koelwyn GJ, et al. 2020. Nat Med. 1452:26. PubMed
  221. Kim SJ, et al. 2020. Cell Mol Immunol. 17:728. PubMed
  222. Robinett RA et al. 2018. Cell systems. 7(1):41-48 . PubMed
  223. Nowlan B, et al. 2019. Haematologica. 105:71. PubMed
  224. Mohamed E, et al. 2020. Immunity. 52(4):668-682.e7.. PubMed
  225. Zhang CR, et al. 2022. Blood Cancer Discov. 3:220. PubMed
  226. Takaku S, et al. 2022. Evid Based Complement Alternat Med. 2022:6122955. PubMed
  227. Wang S, et al. 2021. Commun Biol. 22:. PubMed
  228. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  229. Song J, et al. 2021. Am J Physiol Heart Circ Physiol. 320:H323. PubMed
  230. Bent EH, et al. 2021. Nat Commun. 12:6218. PubMed
  231. Nahrendorf W, et al. 2021. eLife. 10:00. PubMed
  232. Mansouri S, et al. 2020. Mucosal Immunol. 0.954861111. PubMed
  233. Sasaki Y, et al. 2015. PLoS One. 10: 0131176. PubMed
  234. Kalafati L, et al. 2020. Cell. 183:771. PubMed
  235. Burgener SS, et al. 2019. Cell Rep. 27:3646. PubMed
  236. Duarte D, et al. 2018. Cell Stem Cell. 22:64. PubMed
  237. Ivan DC, et al. 2021. Front Immunol. 12:666961. PubMed
  238. Franklin DA, et al. 2020. JCI Insight. 5:. PubMed
  239. Omatsu Y, et al. 2022. Nat Commun. 13:2654. PubMed
  240. Liu W, et al. 2022. J Clin Invest. 132: . PubMed
  241. Schönberger K, et al. 2022. STAR Protoc. 3:101408. PubMed
  242. Njock MS, et al. 2022. J Extracell Vesicles. 11:e12228. PubMed
  243. Calderon B, et al. 2015. J Exp Med. 212: 1497-1512. PubMed
  244. Richardson ET, et al. 2015. PLoS One. 10: 1371. PubMed
  245. Moro T, et al. 2016. PLoS One. 11: 0146592. PubMed
  246. Kobia FM, et al. 2020. PLoS Biol. 18:e3000850. PubMed
  247. Bordas M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  248. Bellomo A, et al. 2020. Immunity. 53(1):127-142.e7. PubMed
  249. Jiang L, et al. 2020. Cell. 183(5):1219-1233.e18. PubMed
  250. Onai N, et al. 2020. Int J Mol Sci. :22. PubMed
  251. Celik H, et al. 2018. Cancer Cell. 34:741. PubMed
  252. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  253. Yousef H, et al. 2019. Nat Med. 25:988. PubMed
  254. Sadhu S, et al. 2021. J Immunol. 207:1812. PubMed
  255. Sun L, et al. 2022. Adv Sci (Weinh). 9:e2104051. PubMed
  256. Canedo T, et al. 2021. Neuropsychopharmacology. 46:2358. PubMed
  257. Johnson RM, et al. 2021. Front Immunol. 11:614697. PubMed
  258. Kiss M, et al. 2020. Cancer Immunol Res. 9:309. PubMed
  259. Gourvest M, et al. 2021. Leukemia. . PubMed
  260. Bagati A, et al. 2020. Cancer Cell. 39(1):54-67.e9. PubMed
  261. Gicheva N, et al. 2016. Biochem Biophys Res Commun. 479:1-4. PubMed
  262. Beauchamp N, et al. 2010. J Virol. 84:10191. PubMed
  263. Wang Y, et al. 2020. eLife. 9:e57438.. PubMed
  264. Yu L, et al. 2020. Nat Commun. 2.045833333. PubMed
  265. McKenzie MD, et al. 2019. Cell Stem Cell. 25:258. PubMed
  266. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  267. Contreras NA, et al. 2019. PLoS Pathog. 15:e1007890. PubMed
  268. Cantor DJ et al. 2019. Cell reports. 26(1):108-118 . PubMed
  269. Baratin M, et al. 2017. Immunity. 47:349. PubMed
  270. Coley WD et al. 2018. F1000Research. 2018 Mar 14 [revised 2018 Jan 1] 0.5125. PubMed
  271. Zhao N, et al. 2018. J Clin Invest. 26:84. PubMed
  272. Shi J, et al. 2022. Front Pharmacol. 12:818326. PubMed
  273. McPhee C, et al. 2013. J Immunol. 191:4581. PubMed
  274. Fujimura N, et al. 2016. Sci Rep. 5:11664. PubMed
  275. Tsunekuni K, et al. 2020. J Clin Med. 9:00. PubMed
  276. Huang WC, et al. 2020. Adv Mater. 32:e2005637. PubMed
  277. Shin M, et al. 2020. Cell Chem Biol. 314:27. PubMed
  278. Kaiser S, et al. 2020. Glia. 68:2427. PubMed
  279. Aggio-Bruce R, et al. 2020. Mol Neurobiol. . PubMed
  280. Santopaolo M, et al. 2021. Front Immunol. 609406:12. PubMed
  281. Molgora M, et al. 2020. Cell. 182:886. PubMed
  282. Asada S, et al. 2018. Nat Commun. 9:2733. PubMed
  283. Kong XF, et al. 2018. Nat Immunol. 19:973. PubMed
  284. Rosen DA, et al. 2019. Sci Transl Med. 11:eaau5266. PubMed
  285. Dokoshi T, et al. 2020. Cell Rep. 30:61. PubMed
  286. Van Den Eeckhout B, et al. 2020. NPJ Vaccines. 0.252777778. PubMed
  287. Süß P, et al. 2020. Cell Reports. 30(12):4082-4095. PubMed
  288. Liu G, et al. 2022. Theranostics. 12:2248. PubMed
  289. Fan HH, et al. 2021. Methods Mol Biol. 2276:203. PubMed
  290. Monteiro LB, et al. 2020. MethodsX. 7:100938. PubMed
  291. Rodriguez-Tirado C, et al. 2022. Cancers (Basel). 14:. PubMed
  292. Lau P, et al. 2022. Cell Mol Immunol. :. PubMed
  293. Harding CL, et al. 2020. Front Cell Infect Microbiol. 10:328. PubMed
  294. Chavez JS, et al. 2022. Cells. 11:. PubMed
  295. Boulch M, et al. 2021. Sci Immunol. 6:. PubMed
  296. Gao P, et al. 2020. Front Immunol. 1.636111111. PubMed
  297. Chen S, et al. 2015. Cancer Res . 7: 519-531. PubMed
  298. Groppa E, et al. 2015. EMBO Mol Med. 2015; 7: 1366 - 1384. PubMed
  299. Gharib S, et al. 2014. J Leukoc Biol. 95:9. PubMed
  300. Alfaro M, et al. 2008. Proc Natl Acad Sci U S A. 105:18366. PubMed
  301. Walker JA, et al. 2020. Immunity. 51(1):104-118. PubMed
  302. Winter C, et al. 2018. Cell Metab. 28:175. PubMed
  303. Tippimanchai DD, et al. 2018. Oncoimmunology. 7:e1438105. PubMed
  304. Mansouri S, et al. 2021. J Immunol. 206:2233. PubMed
  305. Franklin R, et al. 2022. Nat Commun. 13:2350. PubMed
  306. Gawish R, et al. 2022. Elife. 11:. PubMed
  307. Akhand SS, et al. 2020. Cancer Immunol Res. 8:1542. PubMed
  308. Xu G, et al. 2015. Free Radic Biol Med. 87: 15-25. PubMed
  309. Zhang S, et al. 2016. PLoS Pathog. 12: 1005617. PubMed
  310. Saul S, et al. 2019. J Leukoc Biol. N/A. PubMed
  311. Severe N et al. 2019. Cell Stem Cell. 25(4):570-583 . PubMed
  312. Boguslawski KM, et al. 2020. Sci Adv. 6:eaax7515. PubMed
  313. Wang L, et al. 2020. J Nanobiotechnology. 18:38. PubMed
  314. Cai T, et al. 2022. Front Immunol. 13:1009932. PubMed
  315. Scheyltjens I, et al. 2022. Nat Protoc. 17:2354. PubMed
  316. Zhang Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  317. Wang Y, et al. 2022. Nat Cell Biol. 24:230. PubMed
  318. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  319. Xie Z, et al. 2020. Light Sci Appl. 9:161. PubMed
  320. Zhang B, et al. 2021. Front Neurol. 607370:12. PubMed
  321. Young K, et al. 2021. Cell Stem Cell. . PubMed
  322. Lucas ED, et al. 2020. Cell Reports. 33(2):108258. PubMed
  323. Zysset D, et al. 2016. Nat Commun. 7:13151. PubMed
  324. Huanga J, et al. 2013. J Immunol Methods. 387:254. PubMed
  325. Maas SLN, et al. 2020. J Neuroinflammation. 17:120. PubMed
  326. Qi S, et al. 2020. Theranostics. 10:1814. PubMed
  327. Zheng W, et al. 2019. Cell Rep. 29:1747. PubMed
  328. Lalor R, et al. 2019. Nutrients. 11. PubMed
RRID
AB_312798 (BioLegend Cat. No. 101215)
AB_312798 (BioLegend Cat. No. 101216)

Antigen Details

Structure
Integrin family, associates with integrin β2 (CD18), 170 kD
Distribution

Granulocytes, monocytes/macrophages, dendritic cells, NK cells, subsets of T and B cells

Function
Adhesion, chemotaxis
Ligand/Receptor
ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, fibrinogen
Cell Type
B cells, Dendritic cells, Granulocytes, Macrophages, Monocytes, Neutrophils, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Coxon A, et al. 1996. Immunity 5:653.

Gene ID
16409 View all products for this Gene ID 3684 View all products for this Gene ID
UniProt
View information about CD11b on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD11b Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse/human CD11b M1/70 FC
Biotin anti-mouse/human CD11b M1/70 FC
FITC anti-mouse/human CD11b M1/70 FC
PE anti-mouse/human CD11b M1/70 FC,IHC
PE/Cyanine5 anti-mouse/human CD11b M1/70 FC
Purified anti-mouse/human CD11b M1/70 FC,CyTOF®,IP,IHC-F,ICC
PE/Cyanine7 anti-mouse/human CD11b M1/70 FC
Alexa Fluor® 488 anti-mouse/human CD11b M1/70 FC,IHC-F,3D IHC,SB
Alexa Fluor® 647 anti-mouse/human CD11b M1/70 FC,3D IHC,SB
Alexa Fluor® 700 anti-mouse/human CD11b M1/70 FC
Pacific Blue™ anti-mouse/human CD11b M1/70 FC
APC/Cyanine7 anti-mouse/human CD11b M1/70 FC
PerCP/Cyanine5.5 anti-mouse/human CD11b M1/70 FC
PerCP anti-mouse/human CD11b M1/70 FC
Brilliant Violet 421™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 570™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 605™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 650™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 711™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 785™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 510™ anti-mouse/human CD11b M1/70 FC,ICC
Ultra-LEAF™ Purified anti-mouse/human CD11b M1/70 FC,CyTOF®,IP,Block,Depletion,IHC-F,ICC
Purified anti-mouse/human CD11b (Maxpar® Ready) M1/70 FC,CyTOF®
Alexa Fluor® 594 anti-mouse/human CD11b M1/70 IHC-F,FC
PE/Dazzle™ 594 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 750 anti-mouse/human CD11b M1/70 FC
TotalSeq™-A0014 anti-mouse/human CD11b M1/70 PG
Brilliant Violet 750™ anti-mouse/human CD11b M1/70 FC
TotalSeq™-B0014 anti-mouse/human CD11b M1/70 PG
TotalSeq™-C0014 anti-mouse/human CD11b M1/70 PG
Spark NIR™ 685 anti-mouse/human CD11b M1/70 FC
PE/Fire™ 640 anti-mouse/human CD11b M1/70 FC
Spark YG™ 593 anti-mouse/human CD11b M1/70 FC
Spark YG™ 570 anti-mouse/human CD11b M1/70 IHC-F
PE/Fire™ 810 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 810 anti-mouse/human CD11b Antibody M1/70 FC
Spark Blue™ 550 anti-mouse/human CD11b M1/70 FC
Spark UV™ 387 anti-mouse/human CD11b M1/70 FC
PerCP/Fire™ 806 anti-mouse/human CD11b M1/70 FC
PerCP/Fire™ 780 anti-mouse/human CD11b M1/70 FC
Spark Blue™ 574 anti-mouse/human CD11b (Flexi-Fluor™) M1/70 FC
KIRAVIA Blue 520™ anti-mouse/human CD11b M1/70 FC
PE/Fire™ 744 anti-mouse/human CD11b M1/70 FC
Spark PLUS UV395™ anti-mouse/human CD11b M1/70 FC
Spark Red™ 718 anti-mouse/human CD11b (Flexi-Fluor™) M1/70 FC
Go To Top Version: 1    Revision Date: 11/30/2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account